Amphion Innovations Partner Company, Motif BioSciences, Advised in the Design and Development of The Shafallah Center's Genetics Medical Center in Doha, Qatar.NEW YORK New York, state, United States New York, Middle Atlantic state of the United States. It is bordered by Vermont, Massachusetts, Connecticut, and the Atlantic Ocean (E), New Jersey and Pennsylvania (S), Lakes Erie and Ontario and the Canadian province of -- Amphion Innovations plc (LSE LSE - Language Sensitive Editor :AMP)("Amphion"), a leading developer and operator of companies in the life sciences and medical technology sectors, today announced that its partner company, Motif BioSciences, Inc., played an instrumental role in the design and development of The Shafallah Center's Genetics Medical Center (SGMC SGMC Subgroup on Marine Climatology ) at the Shafallah Center for Children with Special Needs, which opened last month in Doha, Qatar. Motif, working with personnel from the Shafallah Center, assisted in the procurement of the design, identified the leading instrument vendors and assisted in installation of the SGMC, a first-of-its-kind genetics laboratory dedicated to conducting research on disorders that afflict the children of Qatar. These include rare autosomal recessive diseases, many of which are unique or first-discovered in the Gulf, as well as more common complex diseases such as autism autism (ô`tĭzəm), developmental disability resulting from a neurological disorder that affects the normal functioning of the brain. It is characterized by the abnormal development of communication skills, social skills, and reasoning. and diabetes. The SGMC will anchor The Shafallah Center's advance to becoming a world-class center of research excellence along with its existing focus on clinical treatment, special education and related medical services. Motif selected the Illumina(R) genotyping BeadLab to anchor the SGMC installation. Illumina's technology platform enables large-scale disease association studies and a complete, end-to-end genetic analysis solution with extensive automation, positive sample tracking, and industry-leading whole-genome scanning performance. According to Richard Morgan, CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. of Amphion and Chairman of Motif, "The opening of The Shafallah Genetics Medical Center is surely one of the most important developments in this region when it comes to performing world class medical research. We are both honored and delighted to be part of this ambitious initiative." About The Shafallah Center The Shafallah Center for Children with Special Needs (www.shafallah.org.qa) was established at the behest of Her Highness Sheikha shei·ka also shei·kha n. Islam A sheik's wife. [Arabic  ay Mozah bint Nasser al Misnad, Consort of His Highness the Emir of the State of Qatar, with the intent of providing comprehensive services for need-based Qatari children. The Center is a non-profit, private institution and it is chaired by Hassan Ali Bin Ali. About Motif Biosciences, Inc. Motif BioSciences, Inc. (http://www.motifbio.com) is a population genetics Population genetics The study of both experimental and theoretical consequences of mendelian heredity on the population level, in contradistinction to classical genetics which deals with the offspring of specified parents on the familial level. company focused on discovering genetic causes of major diseases by interpreting the wealth of genomic data from Arabian Gulf Region. |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion